Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Hormone-free Antral Retrieval for Viable Embryo Storage & Transfer

NCT: NCT07801105 · NOT_YET_RECRUITING

NCT IDNCT07801105
StatusNOT_YET_RECRUITING
Start Date2026-09
Completion2028-03
SponsorKevin Doody (INDUSTRY)
First posted
Last updated

Brief Summary

This study is testing whether eggs can be collected from small follicles without using the usual ovarian stimulation medications. Participants will have up to three egg retrieval procedures. The eggs collected during each retrieval will be matured in the laboratory using the CAPA-IVM process, fertilized, grown into embryos, and tested to identify chromosomally normal embryos. Embryos from the retrievals may be frozen and accumulated. If a suitable embryo is available, one chromosomally normal embryo may be transferred. The study will also monitor safety, hormone levels, follicle development, embryo development, pregnancy results, and how well participants tolerate the study procedures.

Frequently Asked Questions

What is Hormone-free Antral Retrieval for Viable Embryo Storage & Transfer?

Hormone-free Antral Retrieval for Viable Embryo Storage & Transfer is a clinical trial registered under NCT07801105. Current status: NOT_YET_RECRUITING.

What is the status of NCT07801105?

The current status of NCT07801105 (Hormone-free Antral Retrieval for Viable Embryo Storage & Transfer) is: NOT_YET_RECRUITING.

When did Hormone-free Antral Retrieval for Viable Embryo Storage & Transfer start?

Hormone-free Antral Retrieval for Viable Embryo Storage & Transfer started on 2026-09.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.